.png?v=1768820899)
Inside Nephrology: A Weekly Review
Nefrologia
Pediatric Nephrotic Syndrome and Kidney Disease Updates
This episode covers new guidelines for pediatric nephrotic syndrome, kidney stone pathophysiology, ADPKD management, critical care nephrology updates, and the latest CKD recommendations from leading nephrology researchers.
Bibliography
1. A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial.
Authors: Langhorne P, Wu O, Rodgers H, et al.
Journal: Health technology assessment (Winchester, England)
PMID: 28967376
DOI: 10.3310/hta21540
2. Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Authors: Oki R, Izumi Y, Fujita K, et al.
Journal: JAMA neurology
PMID: 35532908
DOI: 10.1001/jamaneurol.2022.0901
3. Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical Trial.
Authors: Walsh TS, Parker RA, Aitken LM, et al.
Journal: JAMA
PMID: 40388916
DOI: 10.1001/jama.2025.7200
4. Oral versus Intravenous Antibiotics for Bone and Joint Infection.
Authors: Li HK, Rombach I, Zambellas R, et al.
Journal: The New England journal of medicine
PMID: 30699315
DOI: 10.1056/NEJMoa1710926
5. Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.
Authors: Weidinger S, Blauvelt A, Papp KA, et al.
Journal: The Journal of allergy and clinical immunology
PMID: 39522654
DOI: 10.1016/j.jaci.2024.10.031
Authors: Langhorne P, Wu O, Rodgers H, et al.
Journal: Health technology assessment (Winchester, England)
PMID: 28967376
DOI: 10.3310/hta21540
2. Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Authors: Oki R, Izumi Y, Fujita K, et al.
Journal: JAMA neurology
PMID: 35532908
DOI: 10.1001/jamaneurol.2022.0901
3. Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical Trial.
Authors: Walsh TS, Parker RA, Aitken LM, et al.
Journal: JAMA
PMID: 40388916
DOI: 10.1001/jama.2025.7200
4. Oral versus Intravenous Antibiotics for Bone and Joint Infection.
Authors: Li HK, Rombach I, Zambellas R, et al.
Journal: The New England journal of medicine
PMID: 30699315
DOI: 10.1056/NEJMoa1710926
5. Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.
Authors: Weidinger S, Blauvelt A, Papp KA, et al.
Journal: The Journal of allergy and clinical immunology
PMID: 39522654
DOI: 10.1016/j.jaci.2024.10.031
